Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Michael Cutrer

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Psychosomatics|January 1, 2013
Longitudinal associations of migraine and depressive symptoms: a cohort analysisJustin S Moon, Jonathan H Smith, Brian D Lahr, et al.
Headache|February 27, 2003
Real-world experiences in migraine therapy with rizatriptanDara Jamieson, F Michael Cutrer, Jerome Goldstein, et al.
Clinical Neurology and Neurosurgery|June 14, 2011
Neurologic symptoms and diagnosis in adults with mast cell diseaseJonathan H Smith, Joseph H Butterfield, Animesh Pardanani, et al.
Fertility and Sterility|October 5, 2010
Migraines and ovarian hyperstimulation syndrome: a dopamine connectionNanette L Rollene, Zaraq Khan, Darrell R Schroeder, et al.
The Journal of Allergy and Clinical Immunology|July 2, 2013
Lack of evidence for intrathecal tryptase synthesis in patients with systemic mastocytosisJonathan H Smith, Melissa R Snyder, Catherine R Weiler, et al.
Pain|June 4, 2013
Inability to self-report pain after a stroke: a population-based studyJonathan H Smith, Kari L Bottemiller, Kelly D Flemming, et al.
Headache|August 2, 2003
2003 Wolff Award: Possible parasympathetic contributions to peripheral and central sensitization during migraineDavid Yarnitsky, Itay Goor-Aryeh, Zahid H Bajwa, et al.
Current Pain and Headache Reports|October 29, 2004
Prioritizing treatment attributes and their impact on selecting an oral triptan: results from the TRIPSTAR ProjectDavid W Dodick, Richard B Lipton, Michel D Ferrari, et al.
Clinical Therapeutics|November 9, 2004
Priorities for triptan treatment attributes and the implications for selecting an oral triptan for acute migraine: a study of US primary care physicians (the TRIPSTAR Project)F Michael Cutrer, Peter J Goadsby, Michel D Ferrari, et al.
Mayo Clinic Proceedings|October 4, 2011
MAP0004, orally inhaled dihydroergotamine for acute treatment of migraine: efficacy of early and late treatmentsStewart J Tepper, Shashidhar H Kori, Peter J Goadsby, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Psychosomatics|January 1, 2013
Longitudinal associations of migraine and depressive symptoms: a cohort analysisJustin S Moon, Jonathan H Smith, Brian D Lahr, et al.
Headache|February 27, 2003
Real-world experiences in migraine therapy with rizatriptanDara Jamieson, F Michael Cutrer, Jerome Goldstein, et al.
Clinical Neurology and Neurosurgery|June 14, 2011
Neurologic symptoms and diagnosis in adults with mast cell diseaseJonathan H Smith, Joseph H Butterfield, Animesh Pardanani, et al.
Fertility and Sterility|October 5, 2010
Migraines and ovarian hyperstimulation syndrome: a dopamine connectionNanette L Rollene, Zaraq Khan, Darrell R Schroeder, et al.
The Journal of Allergy and Clinical Immunology|July 2, 2013
Lack of evidence for intrathecal tryptase synthesis in patients with systemic mastocytosisJonathan H Smith, Melissa R Snyder, Catherine R Weiler, et al.
Pain|June 4, 2013
Inability to self-report pain after a stroke: a population-based studyJonathan H Smith, Kari L Bottemiller, Kelly D Flemming, et al.
Headache|August 2, 2003
2003 Wolff Award: Possible parasympathetic contributions to peripheral and central sensitization during migraineDavid Yarnitsky, Itay Goor-Aryeh, Zahid H Bajwa, et al.
Current Pain and Headache Reports|October 29, 2004
Prioritizing treatment attributes and their impact on selecting an oral triptan: results from the TRIPSTAR ProjectDavid W Dodick, Richard B Lipton, Michel D Ferrari, et al.
Clinical Therapeutics|November 9, 2004
Priorities for triptan treatment attributes and the implications for selecting an oral triptan for acute migraine: a study of US primary care physicians (the TRIPSTAR Project)F Michael Cutrer, Peter J Goadsby, Michel D Ferrari, et al.
Mayo Clinic Proceedings|October 4, 2011
MAP0004, orally inhaled dihydroergotamine for acute treatment of migraine: efficacy of early and late treatmentsStewart J Tepper, Shashidhar H Kori, Peter J Goadsby, et al.
Pageof 5